“Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries”

“Development of a high-throughput platform for discovery of antimicrobial peptides. The screening of 800,000 peptides uncovered thousands of synthetic antimicrobial sequences. The lead peptides exhibit potent antimicrobial activity and distinctive mechanisms.

Peptides have great potential to combat antibiotic resistance. While many platforms can screen peptides for their ability to bind to target cells, there are virtually no platforms that directly assess the functionality of peptides. This limitation is exacerbated when identifying antimicrobial peptides because the phenotype, death, selects against itself and has caused a scientific bottleneck that confines research to a few naturally occurring classes of antimicrobial peptides. The researchers have used this seeming dissonance to develop Surface Localized Antimicrobial Display (SLAY), a platform that allows screening of unlimited numbers of peptides of any length, composition, and structure in a single tube for antimicrobial activity. Using SLAY, they screened ∼800,000 random peptide sequences for antimicrobial function and identified thousands of active sequences, dramatically increasing the number of known antimicrobial sequences. SLAY hits present with different potential mechanisms of peptide action and access to areas of antimicrobial physicochemical space beyond what nature has evolved.”

Source: Cell

Need to know more on AMR? Just attend one of our dedicated courses or masterclass on AMR!


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!